Schonfeld Strategic Advisors’s Psyence Biomedical Warrant PBMWW Stock Holding History

Schonfeld Strategic Advisors’s Portfolio PBMWW Stock Details PBMWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-24,300	Closed	-$1.7K	–	2619
2024 Q1	$1.7K	Buy	+24,300	New	+$1.51K	﹤0.01%	1971

Other funds holding PBMWW

Cowen and Company New York $2.9B AUM 105.26% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Calamos Advisors

Calamos Advisors Naperville, Illinois $25.9B AUM 21.78% 1-Year Est. Return

Cantor Fitzgerald New York $2.76B AUM 29.01% 1-Year Est. Return

Saba Capital Management New York $3.12B AUM 13% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.36B AUM 24.94% 1-Year Est. Return

Anson Funds Management Dallas, Texas $1.57B AUM 370.24% 1-Year Est. Return

Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return

Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return